![Children | Free Full-Text | Use of COVID-19 Convalescent Plasma for Treatment of Symptomatic SARS-CoV-2 Infection at a Children’s Hospital: A Contribution to a Still Inadequate Body of Evidence Children | Free Full-Text | Use of COVID-19 Convalescent Plasma for Treatment of Symptomatic SARS-CoV-2 Infection at a Children’s Hospital: A Contribution to a Still Inadequate Body of Evidence](https://www.mdpi.com/children/children-10-00350/article_deploy/html/images/children-10-00350-g001.png)
Children | Free Full-Text | Use of COVID-19 Convalescent Plasma for Treatment of Symptomatic SARS-CoV-2 Infection at a Children’s Hospital: A Contribution to a Still Inadequate Body of Evidence
![Cells | Free Full-Text | Intensive Care Unit Acquired Weakness Is Associated with Rapid Changes to Skeletal Muscle Proteostasis Cells | Free Full-Text | Intensive Care Unit Acquired Weakness Is Associated with Rapid Changes to Skeletal Muscle Proteostasis](https://pub.mdpi-res.com/cells/cells-11-04005/article_deploy/html/images/cells-11-04005-g001.png?1670745837)
Cells | Free Full-Text | Intensive Care Unit Acquired Weakness Is Associated with Rapid Changes to Skeletal Muscle Proteostasis
![Frontiers | Intermedin Reduces Oxidative Stress and Apoptosis in Ventilator-Induced Lung Injury via JAK2/STAT3 Frontiers | Intermedin Reduces Oxidative Stress and Apoptosis in Ventilator-Induced Lung Injury via JAK2/STAT3](https://www.frontiersin.org/files/MyHome%20Article%20Library/817874/817874_Thumb_400.jpg)
Frontiers | Intermedin Reduces Oxidative Stress and Apoptosis in Ventilator-Induced Lung Injury via JAK2/STAT3
![JCM | Free Full-Text | Bacterial Ventilator-Associated Pneumonia in COVID-19 Patients: Data from the Second and Third Waves of the Pandemic JCM | Free Full-Text | Bacterial Ventilator-Associated Pneumonia in COVID-19 Patients: Data from the Second and Third Waves of the Pandemic](https://pub.mdpi-res.com/jcm/jcm-11-02279/article_deploy/html/images/jcm-11-02279-g001-550.jpg?1650423104)
JCM | Free Full-Text | Bacterial Ventilator-Associated Pneumonia in COVID-19 Patients: Data from the Second and Third Waves of the Pandemic
![Frontiers | Therapeutic implications of current Janus kinase inhibitors as anti-COVID agents: A review Frontiers | Therapeutic implications of current Janus kinase inhibitors as anti-COVID agents: A review](https://www.frontiersin.org/files/Articles/1135145/fphar-14-1135145-HTML/image_m/fphar-14-1135145-g003.jpg)
Frontiers | Therapeutic implications of current Janus kinase inhibitors as anti-COVID agents: A review
![Monoclonal antibody therapy, Remdesivir and other ways Colorado is fighting COVID-19 | Colorado Public Radio Monoclonal antibody therapy, Remdesivir and other ways Colorado is fighting COVID-19 | Colorado Public Radio](https://wp-cpr.s3.amazonaws.com/uploads/2021/05/COVID-ICU-PLATTE-VALLEY-210525-006.jpg)
Monoclonal antibody therapy, Remdesivir and other ways Colorado is fighting COVID-19 | Colorado Public Radio
![Strategies to enhance immunomodulatory properties and reduce heterogeneity in mesenchymal stromal cells during ex vivo expansion - Cytotherapy Strategies to enhance immunomodulatory properties and reduce heterogeneity in mesenchymal stromal cells during ex vivo expansion - Cytotherapy](https://www.isct-cytotherapy.org/cms/attachment/b3e2f362-b367-4c7b-9fd5-b3c8bece7d35/gr1_lrg.jpg)
Strategies to enhance immunomodulatory properties and reduce heterogeneity in mesenchymal stromal cells during ex vivo expansion - Cytotherapy
Design, Synthesis, and Biological Evaluation of HSP90 Inhibitor–SN38 Conjugates for Targeted Drug Accumulation | Journal of Medicinal Chemistry
Targeted Treatments for Chronic Obstructive Pulmonary Disease (COPD) Using Low-Molecular-Weight Drugs (LMWDs) | Journal of Medicinal Chemistry
![JPM | Free Full-Text | Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Autoimmune Rheumatic and Non Rheumatic Diseases JPM | Free Full-Text | Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Autoimmune Rheumatic and Non Rheumatic Diseases](https://www.mdpi.com/jpm/jpm-13-00688/article_deploy/html/images/jpm-13-00688-g001.png)
JPM | Free Full-Text | Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Autoimmune Rheumatic and Non Rheumatic Diseases
![Cytokine storm syndrome in coronavirus disease 2019: A narrative review - Gao - 2021 - Journal of Internal Medicine - Wiley Online Library Cytokine storm syndrome in coronavirus disease 2019: A narrative review - Gao - 2021 - Journal of Internal Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/4aa87ccb-b247-4138-a629-886e4ffd72ff/joim13144-toc-0001-m.png)